Page 6 - Aadi Bioscience News Today

Aadi Bioscience Stock (NASDAQ: AADI) stock price, news, charts, stock research, profile.

  Friday's session saw 59 companies set new 52-week lows.

/PRNewswire/ -- DelveInsights Hypertension Market Insights report includes a comprehensive understanding of current treatment practices, hypertension emerging...

Investing in stocks comes with the risk that the share price will fall. And there's no doubt that Aadi Bioscience, Inc...

Aadi Bioscience, Inc. (NASDAQ:AADI – Free Report) Chairman Neil Desai sold 16,171 shares of the stock in a transaction on Wednesday, July 5th. The stock was sold at an average price of $6.55, for a total transaction of $105,920.05. Following the sale, the chairman now owns 1,763,372 shares of the company’s stock, valued at $11,550,086.60. […]

Aadi Bioscience, Inc. (NASDAQ:AADI – Free Report) Chairman Neil Desai sold 10,000 shares of the business’s stock in a transaction dated Monday, July 3rd. The stock was sold at an average price of $6.64, for a total transaction of $66,400.00. Following the sale, the chairman now directly owns 1,779,543 shares of the company’s stock, valued […]

Aadi Bioscience, Inc. (NASDAQ:AADI – Free Report) Chairman Neil Desai sold 16,171 shares of the business’s stock in a transaction dated Wednesday, July 5th. The stock was sold at an average price of $6.55, for a total transaction of $105,920.05. Following the sale, the chairman now owns 1,763,372 shares in the company, valued at $11,550,086.60. […]

  On Thursday, 109 companies set new 52-week lows.

BriaCell Therapeutics (NASDAQ:BCTX – Free Report) and Aadi Bioscience (NASDAQ:AADI – Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, earnings, profitability, risk and dividends. Insider & Institutional Ownership 16.1% of BriaCell Therapeutics shares […]

BriaCell Therapeutics (NASDAQ:BCTX – Free Report) and Aadi Bioscience (NASDAQ:AADI – Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, profitability, risk, institutional ownership, valuation, dividends and analyst recommendations. Volatility and Risk BriaCell Therapeutics has a beta of […]